2019-2020
First CerviGuard pilot phase
Initial downloadable Win32 TensorFlow-based pilot workflow documented in MDR draft references and planning artifacts.
This page provides Phase 1 proof artifacts: timeline milestones, pilot context, and KPI-definition structure. Numeric KPI publication remains gated until denominator/date-window approvals are complete.
Reported outcomes are cohort-specific, method-bounded, and include explicit limitations. KPI percentages will not be published without denominator and date-window context.
2019-2020
Initial downloadable Win32 TensorFlow-based pilot workflow documented in MDR draft references and planning artifacts.
2022
Multiple projects and research tracks were finalized before broader platform expansion.
2024
Company launch milestones and online product transition documented in internal/public planning artifacts.
2025
In 2025, SmartClover signed a partnership for the TealGuard project, focused on next-generation prophylaxis management for gynecological oncological pathologies.
| KPI name | Numerator | Denominator | Cohort window | Method | Caveat |
|---|---|---|---|---|---|
| Case review turnaround improvement | Cases completed inside target review window post-deployment | All eligible cases in selected cohort | Pending publication | Pre/post cohort comparison with fixed inclusion criteria | Workflow mix can vary by site |
| Follow-up adherence uplift | Cases with completed follow-up within defined interval | Cases assigned follow-up action | Pending publication | Operational follow-up completion tracking | External care-path variability applies |
| AI-assisted triage agreement rate | Cases where AI support category aligns with clinician final category | Cases containing both AI output and clinician adjudication | Pending publication | Blinded adjudication and reconciliation rules | Not a standalone diagnostic-accuracy claim |